AUS
NZ
UK
CA
USA
IND
Healthcare
AstraZeneca’s Tagrisso Gains European Approval for Advanced Lung Cancer Treatment
December 23, 2024 10:07 AM GMT| By Team Kalkine MediaHighlights:,European Approval:,AstraZeneca’s Tagrisso has been approved in Europe for treating unresectable EGFR-mutated non-small cell lung cancer (NSCLC).,Prolonged Disease Control:,Clinical trials showed patients on Tagrisso experienced over three...
GSK (LON:GSK) Faces 42% Decline Over Five Years Amid EPS Challenges
December 23, 2024 09:32 AM GMT| By Team Kalkine MediaHighlights,Long-Term Decline,GSK’s share price dropped 42% over five years, reflecting consistent EPS reductions.,Market Sentiment Stable,Share price trends closely aligned with EPS performance, indicating limited sentiment shifts.,Dividend Impact,To...
Analyzing Ownership Dynamics in Avacta Group Plc (LON:AVCT)
December 20, 2024 11:06 AM GMT| By Team Kalkine MediaHighlights,Individual investors hold 57% of,Avacta,Group Plc (,LON:AVCT,),,benefitting,most from stock movements.,Institutional investors, owning 41%, reflect confidence in the company’s growth potential.,Insider ownership is below 1%, with the board...
Synairgen Secures Conditional £18 Million Funding for Key Clinical Trials
December 20, 2024 08:09 AM GMT| By Team Kalkine MediaHighlights:,Major Funding Secured:,Synairgen raises £18 million conditionally through TFG Asset Management, with an additional £6 million targeted through other fundraising initiatives.,Strategic Allocation:,Proceeds will fund a Phase 2 trial of SNG0...
NIOX Group's Impressive Five-Year Performance
December 19, 2024 02:08 PM GMT| By Team Kalkine MediaHighlights,NIOX Group (NIOX) shares surged by 237% over the past five years.,Profitability marked a significant inflection point, contributing to strong earnings growth.,Total shareholder return (TSR) over five years reached 237%, outperforming share...
Hemogenyx Partners with Kure.ai to Revolutionise CAR-T Cell Therapy Production
December 19, 2024 10:22 AM GMT| By Team Kalkine MediaHighlights:,Hemogenyx partners with Kure.ai to develop an ultrafast manufacturing (UM) process for CAR-T therapies.,The collaboration targets faster, scalable production for AML and KMT2A-rearranged ALL treatments.,Hemogenyx gains an option to licens...
Understanding Oxford Nanopore Technologies' (LON:ONT) Elevated P/S Ratio
December 19, 2024 10:15 AM GMT| By Team Kalkine MediaHighlights,High P/S Ratio,Oxford Nanopore Technologies (ONT) has a price-to-sales (P/S) ratio of 8.1x, significantly higher than the industry average.,Strong Revenue Growth Forecast,Analysts project 26% annual revenue growth for the company over the...
Intelligent Ultrasound Group Agrees to £45M Acquisition by Surgical Science Sweden
December 19, 2024 10:02 AM GMT| By Team Kalkine MediaHighlights:,Intelligent Ultrasound Group PLC to be acquired by Surgical Science Sweden in a £45 million cash deal.,The offer represents a 17% premium to the prior day’s closing price and a 31.1% premium to the one-year average.,The acquisition aims t...
Surgical Science Announces £45.2 Million Acquisition of Intelligent Ultrasound
December 19, 2024 07:55 AM GMT| By Team Kalkine MediaHighlights,Surgical Science Sweden AB to acquire Intelligent Ultrasound Group plc for £45.2 million in a cash deal.,Acquisition represents a premium of up to 79.3% over Intelligent Ultrasound’s recent share price.,Strategic alignment to strengthen me...
Pfizer Signals Stability with 2025 Growth Guidance Amid Investor Concerns
December 17, 2024 05:27 PM GMT| By Team Kalkine MediaHighlights:,Revenue Growth Forecast:,Pfizer expects up to 5% revenue growth, aligning with market expectations.,Earnings Outlook Strong:,Per-share earnings are projected to rise by up to 18% next year.,Covid-19 Revenue Steady:,Product revenue from Co...
ANGLE’s Parsortix System Gains Validation in HER2 Breast Cancer Testing
December 13, 2024 10:48 AM GMT| By Team Kalkine MediaHighlights:,Independent study validates the Parsortix system for HER2-positive breast cancer testing.,HER2 status shifts identified in circulating tumour cells (CTCs), offering new treatment options.,Potential to extend HER2 antibody-drug conjugates...
Institutional Ownership at PureTech Health plc (LON:PRTC)
December 13, 2024 12:00 AM GMT| By Team Kalkine MediaHighlights,71% of PureTech Health’s stock is held by institutional investors.,Invesco Ltd. is the largest shareholder with 17% ownership.,Insider ownership stands at £27 million, with the general public owning 12%.,PureTech Health plc (LON:PRTC), a p...
Genus (LON:GNS) Stock Performance and Recent Developments
December 13, 2024 12:00 AM GMT| By Team Kalkine MediaHighlights,Genus (GNS) stock has fluctuated between GBX 1,478 and GBX 2,378 over the past year.,The company operates in the animal genetics industry across global markets, including North America and Europe.,Insider trading activity revealed a recent...
hVIVO Publishes World-First COVID-19 Characterisation Study in Nature Communications
December 12, 2024 11:38 AM GMT| By Team Kalkine MediaHighlights:,First-of-its-kind COVID-19 characterisation trial identifies key blood biomarkers.,Study confirms safety and detailed progression insights of SARS-CoV-2 in human challenge trials.,Early biomarkers show potential for improved infection dia...
HUTCHMED (China) Limited (AIM: HCM; HKEX: 13) Receives Breakthrough Therapy Designation for ORPATHYS® and TAGRISSO® Combination for NSCLC Treatment
December 12, 2024 07:32 AM GMT| By Team Kalkine MediaHighlights,HUTCHMED's combination of ORPATHYS® and TAGRISSO® receives Breakthrough Therapy Designation (BTD) from NMPA.,Combination treatment aims to address unmet needs in EGFR mutation-positive NSCLC with MET amplification.,Ongoing Phase III SACHI...
Indivior (LON:INDV) Sees Decline Amid Reduced Trading Activity
December 12, 2024 12:00 AM GMT| By Team Kalkine MediaHighlights,Indivior (INDV) shares fell by 1.2% on Wednesday.,Trading volume saw a drastic drop, with shares down by 81%.,The company faces significant financial indicators that highlight underlying risks.,Indivior PLC (LON:INDV), a leader in the deve...
Uniphar (LON:UPR) Faces a 1.1% Drop in Stock Price Amid Reduced Trading Volume
December 12, 2024 12:00 AM GMT| By Team Kalkine MediaHighlights,Uniphar (UPR) shares dropped by 1.1% on Wednesday.,Trading volume significantly decreased by 82%, signaling reduced market activity.,The stock’s 50-day moving average stands at GBX 191.85, indicating a shift in short-term price trends.,Uni...
EKF Diagnostics (LON:EKF) Sees Positive Movement in Stock Price
December 12, 2024 12:00 AM GMT| By Team Kalkine MediaHighlights,Stock price rose by 0.8%,on Wednesday, showing positive momentum for EKF Diagnostics (EKF).,Increased trading volume by over 1,000%,signals notable interest in the stock.,Key metrics include a market cap of £109.80 million,and a relatively...
Genus plc (LON:GNS) Sees Positive Movement Despite Insider Activity
December 11, 2024 12:00 AM GMT| By Team Kalkine MediaHighlights,Genus (GNS) shares rose by 1.1% on Wednesday.,Shore Capital upgraded Genus to a rating.,Insider Jorgen Kokke sold 2,186 shares at an average price of GBX 1,956.,Genus plc (LON:GNS), a leader in animal genetics, saw its stock rise by 1.1% o...
hVIVO Signs £11.5 Million Contract with Global Pharma Client for RSV Human Challenge Trial
December 10, 2024 08:10 AM GMT| By Team Kalkine MediaHighlights,hVIVO signs £11.5 million contract with a leading global pharmaceutical client for an RSV challenge trial.,The trial will evaluate an antiviral candidate's safety, pharmacokinetics, and activity, leveraging hVIVO’s FluCamp recruitment arm....
